Developing new treatments to combat bacterial resistance using biopharmaceuticals
Official title: Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
Funded at International AIDS Vaccine Initiative · NIH-10934766 · Data updated 2026-11-12
This study is working on new treatments to help fight infections caused by bacteria that are hard to treat, using special tools like antibodies and RNA, and it's designed for anyone interested in better options for managing these tough infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 8, 2023 |
| Project end | September 7, 2030 |
| Funding year | 2023 |
| Award (this year) | $3,796 |
| NIH project number | 75N93023D00010-0-759302300001-1 |
| Project ID | NIH-10934766 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with infections that are resistant to current antibiotic treatments.
✕Less likely to help
Patients with infections that are not caused by bacterial pathogens or those who do not have drug-resistant infections may not benefit from this research.
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It involves creating and evaluating various biological materials, including monoclonal antibodies and small interfering RNA (siRNA) vectors, to enhance treatment options for infectious diseases. The program provides comprehensive services such as product development planning, assay development, and regulatory support to ensure effective translation of these therapies into clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for patients suffering from infections caused by drug-resistant bacteria.
How similar studies have gone: Other research in the field of biopharmaceuticals and antibacterial resistance has shown promise, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Developing and producing new vaccines for infectious diseases.
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.